GERN
Geron Corp
Price:  
4.66 
USD
Volume:  
12,880,477.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN EV/EBITDA

-240.3%
Upside

As of 2024-07-27, the EV/EBITDA ratio of Geron Corp (GERN) is -12.67. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GERN's latest enterprise value is 2,656.97 mil USD. GERN's TTM EBITDA according to its financial statements is -209.66 mil USD. Dividing these 2 quantities gives us the above GERN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 12.2x - 21.5x 16.6x
Forward P/E multiples 17.8x - 24.1x 21.4x
Fair Price (6.11) - (7.42) (6.54)
Upside -231.1% - -259.2% -240.3%
4.66 USD
Stock Price
(6.54) USD
Fair Price

GERN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-07-26 -12.67
2024-07-25 -11.63
2024-07-24 -11.63
2024-07-23 -12.56
2024-07-22 -12.73
2024-07-19 -12.50
2024-07-18 -12.70
2024-07-17 -12.96
2024-07-16 -13.61
2024-07-15 -13.35
2024-07-12 -12.81
2024-07-11 -12.96
2024-07-10 -12.50
2024-07-09 -12.45
2024-07-08 -12.30
2024-07-05 -12.30
2024-07-03 -11.82
2024-07-02 -11.29
2024-07-01 -11.77
2024-06-28 -11.48
2024-06-27 -12.05
2024-06-26 -12.08
2024-06-25 -12.28
2024-06-24 -12.47
2024-06-21 -12.64
2024-06-20 -12.11
2024-06-18 -12.19
2024-06-17 -12.70
2024-06-14 -13.27
2024-06-13 -13.30
2024-06-12 -13.89
2024-06-11 -13.89
2024-06-10 -13.75
2024-06-07 -12.47
2024-06-06 -10.49
2024-06-05 -10.81
2024-06-04 -10.78
2024-06-03 -10.32
2024-05-31 -9.53
2024-05-30 -9.31
2024-05-29 -8.88
2024-05-28 -8.97
2024-05-24 -9.33
2024-05-23 -9.36
2024-05-22 -9.84
2024-05-21 -9.96
2024-05-20 -10.04
2024-05-17 -10.27
2024-05-16 -10.52
2024-05-15 -10.52